Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients

• Published in: Scientific reports Vol. 12; no. 1; p. 18900
• Main Authors: Iwadare, Takanobu, Kimura, Takefumi, Tanaka, Naoki, Yamazaki, Tomoo, Wakabayashi, Shun-ichi, Okumura, Taiki, Kobayashi, Hiroyuki, Yamashita, Yuki, Pydi, Sai P., Nakajima, Tomoyuki, Iwaya, Mai, Sugiura, Ayumi, Joshita, Satoru, Uehara, Takeshi, Umemura, Takeji
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 07.11.2022; Nature Publishing Group; Nature Portfolio
• Subjects: 692/4020; 692/53; 692/699; Aspartate Aminotransferases; Biomarkers; Biopsy; Collagen; Fatty liver; Fibrin; Fibrosis; Genetic analysis; Glycoproteins; Hepacivirus - genetics; Hepatitis C; Hepatitis C - complications; Hepatitis C, Chronic - complications; Hepatitis C, Chronic - pathology; Humanities and Social Sciences; Humans; Liver; Liver - pathology; Liver Cirrhosis - pathology; Liver diseases; multidisciplinary; Retrospective Studies; Science; Science (multidisciplinary); Severity of Illness Index; Thrombospondin; Thrombospondins - genetics
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-23357-9

Among several secreted glycoproteins belonging to the thrombospondin family, thrombospondin 2 (TSP2) is involved in various functions, including collagen/fibrin formation. Liver/serum TSP2 levels have been correlated to liver fibrosis stage and disease activity in nonalcoholic fatty liver disease. This study investigated whether serum TSP2 was associated with clinicopathological features in hepatitis C virus (HCV)-infected patients as well. A total of 350 patients with HCV who had undergone liver biopsy were retrospectively enrolled and divided into a discovery cohort (n = 270) and a validation cohort (n = 80). In the discovery cohort, serum TSP2 levels were moderately correlated with both liver fibrosis stage ( r  = 0.426, P < 0.0001) and activity grade ( r  = 0.435, P < 0.0001). The area under the receiver operating characteristic curve of TSP2 for predicting severe fibrosis (≥ F3) was 0.78 and comparable to or better than those of autotaxin (0.78), FIB-4 index (0.78), and APRI (0.76). The discovery cohort findings were closely replicated in the validation cohort. Moreover, comprehensive liver genetic analysis of HCV-infected patients confirmed that the expression of the THBS2 gene encoding TSP2 was significantly higher in severely fibrotic F4 than in F1 patients. Circulating TSP2 levels may reflect the severity of hepatic fibrosis/inflammation in HCV-infected patients.